日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Inequitable Conduct and Invalidation of Patents Related to Food and Drug Administration-Regulated Products

不公平行为和与食品药品监督管理局监管产品相关的专利无效

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2023.20196
Tu, S Sean; Leadmon, Caroline; Daval, C Joseph Ross; Kesselheim, Aaron S
发表日期：2023
文献求助 收藏

Biodiversity of Convolvulaceous species that contain Ergot Alkaloids, Indole Diterpene Alkaloids, and Swainsonine

含有麦角生物碱、吲哚二萜生物碱和斯温森碱的旋花科植物的生物多样性

期刊:Biochemical Systematics and Ecology
影响因子:2
doi:10.1016/j.bse.2019.103921
Cook, Daniel; Lee, Stephen T; Panaccione, Daniel G; Leadmon, Caroline E; Clay, Keith; Gardner, Dale R
发表日期：2019
文献求助 收藏

Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use

采用“即时”普乐沙福动员造血祖细胞的方法是一种比常规使用普乐沙福更具成本效益的替代方案。

期刊:Cytotherapy
影响因子:3.2
doi:10.1016/j.jcyt.2015.09.002
Veltri, Lauren; Cumpston, Aaron; Shillingburg, Alexandra; Wen, Sijin; Luo, Jin; Leadmon, Sonia; Watkins, Kathy; Craig, Michael; Hamadani, Mehdi; Kanate, Abraham S
细胞生物学
发表日期：2015
文献求助 收藏

Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning

对于接受氟达拉滨联合白消安减毒预处理方案后进行异基因造血干细胞移植的患者，增加白消安剂量强度并不能改善其预后。

期刊:Hematological Oncology
影响因子:3.9
doi:10.1002/hon.985
Hamadani, Mehdi; Craig, Michael; Phillips, Gary S; Abraham, Jame; Tse, William; Cumpston, Aaron; Gibson, Laura; Remick, Scot C; Bunner, Pamela; Leadmon, Sonia; Elder, Patrick; Hofmeister, Craig; Penza, Sam; Efebera, Yvonne; Andritsos, Leslie; Garzon, Ramiro; Benson, Don M Jr; Blum, William; Devine, Steven M
细胞生物学
发育与干细胞
干细胞
发表日期：2011
文献求助 收藏